Improving postpartum hemorrhage care: Policy, practice, and research
- PMID: 35762809
- DOI: 10.1002/ijgo.14271
Improving postpartum hemorrhage care: Policy, practice, and research
Keywords: PPH prevention; PPH treatment; clinical guidelines; essential medicine list; heat stable carbetocin; quality of care; tranexamic acid.
References
REFERENCES
-
- World Health Organization. Trends in maternal mortality 2000 to 2017: Estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division: Executive summary. WHO; 2019.
-
- FIGO PPH Technical Working Group; Begum F, Beyeza J, Burke T, et al. FIGO and the International Confederation of Midwives endorse WHO guidelines on prevention and treatment of postpartum hemorrhage. 2022;158(s1):6-10. doi:10.1002/ijgo.14199.
-
- World Health Organization. WHO recommendations: Uterotonics for the prevention of postpartum haemorrhage. WHO; 2018.
-
- World Health Organization. WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage. WHO; 2017.
-
- Ng'ang'a J, Chitimbe T, Mburu R, et al. Challenges in updating national guidelines and essential medicines lists in Sub-Saharan African countries to include WHO-recommended postpartum hemorrhage medicines. 2022;158(s1):11-13. doi:10.1002/ijgo.14269.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
